Literature DB >> 11481489

Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3.

A W Roberts1, L Robb, S Rakar, L Hartley, L Cluse, N A Nicola, D Metcalf, D J Hilton, W S Alexander.   

Abstract

Mice lacking suppressor of cytokine signaling 3 (SOCS3) exhibited embryonic lethality with death occurring between days 11 and 13 of gestation. At this stage, SOCS3(-/-) embryos were slightly smaller than wild type but appeared otherwise normal, and histological analysis failed to detect any anatomical abnormalities responsible for the lethal phenotype. Rather, in all SOCS3(-/-) embryos examined, defects were evident in placental development that would account for their developmental arrest and death. The placental spongiotrophoblast layer was significantly reduced and accompanied by increased numbers of giant trophoblast cells. Delayed branching of the chorioallantois was evident, and, although embryonic blood vessels were present in the labyrinthine layer of SOCS3(-/-) placentas, the network of embryonic vessels and maternal sinuses was poorly developed. Yolk sac erythropoiesis was normal, and, although the SOCS3(-/-) fetal liver was small at day 12.5 of gestation (E12.5), normal frequencies of erythroblasts and hematopoietic progenitor cells, including blast forming unit-erythroid (BFU-E) and, colony forming unit-erythroid (CFU-E) were present at both E11.5 and E12.5. Colony formation for both BFU-E and CFU-E from SOCS3(-/-) mice displayed wild-type quantitative responsiveness to erythropoietin (EPO), in the presence or absence of IL-3 or stem cell factor (SCF). These data suggest that SOCS3 is required for placental development but dispensable for normal hematopoiesis in the mouse embryo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11481489      PMCID: PMC55419          DOI: 10.1073/pnas.161271798

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

Review 1.  The challenges of translating knockout phenotypes into gene function.

Authors:  J N Ihle
Journal:  Cell       Date:  2000-07-21       Impact factor: 41.582

2.  Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130.

Authors:  S E Nicholson; D De Souza; L J Fabri; J Corbin; T A Willson; J G Zhang; A Silva; M Asimakis; A Farley; A D Nash; D Metcalf; D J Hilton; N A Nicola; M Baca
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

3.  SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130.

Authors:  J Schmitz; M Weissenbach; S Haan; P C Heinrich; F Schaper
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

4.  Targeted disruption of the MHC class II Aa gene in C57BL/6 mice.

Authors:  F Köntgen; G Süss; C Stewart; M Steinmetz; H Bluethmann
Journal:  Int Immunol       Date:  1993-08       Impact factor: 4.823

5.  SOCS3 is essential in the regulation of fetal liver erythropoiesis.

Authors:  J C Marine; C McKay; D Wang; D J Topham; E Parganas; H Nakajima; H Pendeville; H Yasukawa; A Sasaki; A Yoshimura; J N Ihle
Journal:  Cell       Date:  1999-09-03       Impact factor: 41.582

6.  Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins.

Authors:  J A Hansen; K Lindberg; D J Hilton; J H Nielsen; N Billestrup
Journal:  Mol Endocrinol       Date:  1999-11

7.  Gigantism in mice lacking suppressor of cytokine signalling-2.

Authors:  D Metcalf; C J Greenhalgh; E Viney; T A Willson; R Starr; N A Nicola; D J Hilton; W S Alexander
Journal:  Nature       Date:  2000-06-29       Impact factor: 49.962

8.  CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2.

Authors:  A Sasaki; H Yasukawa; T Shouda; T Kitamura; I Dikic; A Yoshimura
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

Review 9.  SOCS: physiological suppressors of cytokine signaling.

Authors:  D L Krebs; D J Hilton
Journal:  J Cell Sci       Date:  2000-08       Impact factor: 5.285

10.  CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation.

Authors:  A Suzuki; T Hanada; K Mitsuyama; T Yoshida; S Kamizono; T Hoshino; M Kubo; A Yamashita; M Okabe; K Takeda; S Akira; S Matsumoto; A Toyonaga; M Sata; A Yoshimura
Journal:  J Exp Med       Date:  2001-02-19       Impact factor: 14.307

View more
  108 in total

1.  SOCS3 deletion in B cells alters cytokine responses and germinal center output.

Authors:  Sarah A Jones; Christine A White; Lorraine Robb; Warren S Alexander; David M Tarlinton
Journal:  J Immunol       Date:  2011-11-09       Impact factor: 5.422

Review 2.  Biology and significance of the JAK/STAT signalling pathways.

Authors:  Hiu Kiu; Sandra E Nicholson
Journal:  Growth Factors       Date:  2012-02-20       Impact factor: 2.511

3.  Enforced SOCS1 and SOCS3 expression attenuates Lck-mediated cellular transformation.

Authors:  John C Cooper; Mingjian Shi; Fu-Yu Chueh; Srividya Venkitachalam; Chao-Lan Yu
Journal:  Int J Oncol       Date:  2010-05       Impact factor: 5.650

Review 4.  Negative regulation of cytokine signaling.

Authors:  Akihiko Yoshimura
Journal:  Clin Rev Allergy Immunol       Date:  2005-06       Impact factor: 8.667

5.  YB-1 is important for late-stage embryonic development, optimal cellular stress responses, and the prevention of premature senescence.

Authors:  Zhi Hong Lu; Jason T Books; Timothy J Ley
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

6.  Genetic deletion of murine SPRY domain-containing SOCS box protein 2 (SSB-2) results in very mild thrombocytopenia.

Authors:  S L Masters; K R Palmer; W S Stevenson; D Metcalf; E M Viney; N S Sprigg; W S Alexander; N A Nicola; S E Nicholson
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

7.  BRUCE, a giant E2/E3 ubiquitin ligase and inhibitor of apoptosis protein of the trans-Golgi network, is required for normal placenta development and mouse survival.

Authors:  Kristina Lotz; George Pyrowolakis; Stefan Jentsch
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

8.  Reconstruction of an active SOCS3-based E3 ubiquitin ligase complex in vitro: identification of the active components and JAK2 and gp130 as substrates.

Authors:  Nadia J Kershaw; Artem Laktyushin; Nicos A Nicola; Jeffrey J Babon
Journal:  Growth Factors       Date:  2014-01-20       Impact factor: 2.511

9.  Leukemia inhibitory factor regulates trophoblast giant cell differentiation via Janus kinase 1-signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway.

Authors:  Yutaka Takahashi; Michiko Takahashi; Nick Carpino; Shiann-Tarng Jou; Jyh-Rong Chao; Satoshi Tanaka; Yasufumi Shigeyoshi; Evan Parganas; James N Ihle
Journal:  Mol Endocrinol       Date:  2008-05-01

10.  Myeloid depletion of SOCS3 enhances LPS-induced acute lung injury through CCAAT/enhancer binding protein δ pathway.

Authors:  Chunguang Yan; Peter A Ward; Ximo Wang; Hongwei Gao
Journal:  FASEB J       Date:  2013-04-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.